PS
GILD icon

Planned Solutions’s Gilead Sciences GILD Stock Holding History

Planned Solutions’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349K Buy
2,762
+54
+2% +$7.12K 0.1% 102
2026
Q1 		$377K Sell
2,708
-180
-6% -$25.2K 0.12% 81
2025
Q4 		$354K Sell
2,888
-269
-9% -$32.7K 0.11% 88
2025
Q3 		$350K Hold
3,157
– – 0.12% 89
2025
Q2 		$350K Hold
3,157
– – 0.13% 80
2025
Q1 		$354K Hold
3,157
– – 0.14% 71
2024
Q4 		$292K Hold
3,157
– – 0.12% 80
2024
Q3 		$265K Buy
+3,157
New +$241K 0.11% 86
2024
Q1 		– Sell
-2,242
Closed -$182K – 260
2023
Q4 		$182K Buy
+2,242
New +$174K 0.09% 96

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Planned Solutions's GILD Position: Q2 2026 in Review

Planned Solutions increased its Gilead Sciences (GILD) stake by 2% in Q2 2026, buying an estimated $7.12K and bringing the position to 2,762 shares worth $349K. The position accounts for 0.1% of the portfolio, ranked #102.

Planned Solutions first reported a position in GILD in Q4 2023 and has held it in 9 quarters since. The position peaked at $377K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Planned Solutions held 2,762 shares of Gilead Sciences worth $349K as of Q2 2026.
  • Planned Solutions bought 54 Gilead Sciences shares in Q2 2026, an estimated $7.12K.
  • Gilead Sciences made up 0.1% of Planned Solutions's portfolio in Q2 2026, its #102 holding.
  • Planned Solutions first reported a position in Gilead Sciences in Q4 2023 and has held it in 9 quarters since.
  • Planned Solutions's Gilead Sciences position peaked at $377K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Planned Solutions's 13F filing for Q2 2026, filed 13 Jul 2026.